Blue Owl Marks Loparex Debt Near Zero as Default Risk Rises

Blue Owl Capital’s (NYSE: OWL) flagship publicly traded business development company has sharply reduced the value of loans to Loparex, with some of the packaging-materials company’s debt now marked at a fraction of its value at the end of 2025. OBDC currently values Loparex’s second-lien debt at about 5 cents on the dollar, according to regulatory filings. The same debt was marked at roughly 63 cents as of March 31 and about 88 cents at the end of last year.

A first-lien loan that had been valued near par at year-end is now marked at about 22 cents on the dollar.The reductions followed the collapse of a planned transaction that Loparex had been pursuing to bring new equity into the business and improve its liquidity and balance sheet. OBDC President Logan Nicholson said during an Aug. 6 earnings call that the proposed M&A transaction ultimately did not proceed, leading Blue Owl to reduce the value of its position during the quarter. 

OBDC subsequently placed Loparex on non-accrual status after the second quarter, a designation used when full repayment is in doubt. Non-accrual investments represented 0.8% of OBDC’s portfolio at fair value. The deterioration has also been reflected in Loparex’s credit ratings. Moody’s Ratings this week classified the company as being in default and said a Chapter 11 bankruptcy filing was a possible outcome.

Loparex had already faced debt-related pressure before the latest markdowns. The company did not make a June interest payment on its second-lien debt and is operating under a forbearance agreement through September.

S&P Global Ratings had raised concerns about the company’s capital structure in 2024 after Loparex completed a distressed debt exchange that the ratings firm treated as equivalent to a default. S&P said at the time that the company’s capital structure remained unsustainable. At the beginning of 2026, Loparex sought $1.5 billion from private credit lenders as it looked to refinance first- and second-lien obligations, including debt scheduled to mature early next year. Loparex is backed by Pamplona Capital Management. Representatives for Pamplona and Loparex could not be reached for comment, while Blue Owl referred to Nicholson’s comments from the company’s recent earnings call.

The rapid change in Loparex’s loan valuations comes as marks on distressed private-credit investments remain under scrutiny. Because privately held loans do not continuously trade in public markets, business development companies periodically determine their fair values, which can result in differences between lenders when a borrower encounters financial difficulty.

The current valuations also do not necessarily represent Blue Owl’s eventual recovery. The amount recovered could differ if Loparex reaches a restructuring agreement or secures another buyer. Private credit funds are also facing increased redemption requests from retail investors while questions persist around underwriting and the industry’s exposure to software and technology borrowers. The private credit market totals about $1.8 trillion.

About Blue Owl Capital

Blue Owl Capital (NYSE: OWL) is a New York-based alternative asset manager operating across credit, real assets and GP Strategic Capital. The firm was formed from the combination of Owl Rock and Dyal Capital and began trading on the New York Stock Exchange in 2021 under the ticker OWL.

At the time of publishing, Stocks.News does not hold positions in companies mentioned in the article.